BioNexus Gene Lab Corp. (BGLC) Operating income 2018–2025
BioNexus Gene Lab Corp. (BGLC) annual operating income history from SEC filings — each fiscal year as reported.
-$3.0MFY2025 · since FY2018: $59,901 → -$3.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.0M | -88.4% |
| FY2024 | -$1.6M | +39.3% |
| FY2023 | -$2.6M | -790.7% |
| FY2022 | -$291,177 | -127.6% |
| FY2021 | $1.1M | -17.1% |
| FY2020 | $1.3M | +562.0% |
| FY2019 | -$275,705 | -560.3% |
| FY2018 | $59,901 | — |
Source: SEC XBRL filings · For reference only · Not investment advice